| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.00041 | 1 |